Correspondence 0001493152-23-005802 from MANGOCEUTICALS, INC. (MGRX)

MANGOCEUTICALS, INC.
Date: Feb. 22, 2023 · CIK: 0001938046 · Accession: 0001493152-23-005802

View on Edgar

AI Filing Summary & Sentiment

Sentiment

Urgency

Document Type

Confidence

SEC Posture

Company Posture

Summary

Reasoning

File numbers found in text: 333-269240

Date

Feb. 22, 2023

Author

/s/

Form

CORRESP

Company

MANGOCEUTICALS, INC.

Letter

Re:

February 22, 2023

VIA EDGAR

Division of Corporation Finance

U.S. Securities & Exchange Commission

F Street, NE

Washington, DC 20549

Attn: Office of Industrial Applications and Services

Withdrawal of Acceleration Request of Mangoceuticals, Inc.

Registration Statement on Form S-1

File No. 333-269240

Attention: Mr. Jimmy McNamara

Mr. Joe McCann

Withdrawal of Acceleration Request

Mr. McNamara:

Reference is made to our letter, filed as correspondence via EDGAR on February 10, 2023, in which the undersigned registrant, Mangoceuticals, Inc., a Texas corporation (the “Company”), requested acceleration of the effectiveness of the above referenced Registration Statement on Form S-1 (the “Registration Statement”) to Tuesday, February 14, 2023, at 4:00 p.m., Eastern Time, or as soon thereafter as practicable (the “Effective Time”), in accordance with Rule 461 under the Securities Act of 1933, as amended.

The Company is no longer requesting that such Registration Statement be declared effective at the Effective Time and we hereby formally withdraw our request for acceleration of the effective date until further notice from the Company.

Sincerely,
/s/
Jacob Cohen

Show Raw Text

CORRESP
1
filename1.htm

February
22, 2023

VIA
EDGAR

Division
of Corporation Finance

U.S.
Securities & Exchange Commission

100
F Street, NE

Washington,
DC 20549

Attn:
Office of Industrial Applications and Services

    Re:

    Withdrawal
    of Acceleration Request of Mangoceuticals, Inc.

    Registration
    Statement on Form S-1

    File
    No. 333-269240

    Attention:
    Mr.
    Jimmy McNamara

    Mr.
    Joe McCann

Withdrawal
of Acceleration Request

Mr.
McNamara:

Reference
is made to our letter, filed as correspondence via EDGAR on February 10, 2023, in which the undersigned registrant, Mangoceuticals, Inc.,
a Texas corporation (the “Company”), requested acceleration of the effectiveness of the above referenced Registration
Statement on Form S-1 (the “Registration Statement”) to Tuesday, February 14, 2023, at 4:00 p.m., Eastern Time, or
as soon thereafter as practicable (the “Effective Time”), in accordance with Rule 461 under the Securities Act of
1933, as amended.

The
Company is no longer requesting that such Registration Statement be declared effective at the Effective Time and we hereby formally withdraw
our request for acceleration of the effective date until further notice from the Company.

    Sincerely,

    /s/
    Jacob Cohen

    Jacob
    Cohen

    Chief
    Executive Officer

SecProbe.io